129 related articles for article (PubMed ID: 17925094)
1. Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia.
Matayatsuk C; Poljak A; Bustamante S; Smythe GA; Kalpravidh RW; Sirankapracha P; Fucharoen S; Wilairat P
Redox Rep; 2007; 12(5):219-28. PubMed ID: 17925094
[TBL] [Abstract][Full Text] [Related]
2. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation and antioxidant status in beta-thalassemia.
Meral A; Tuncel P; Sürmen-Gür E; Ozbek R; Oztürk E; Günay U
Pediatr Hematol Oncol; 2000 Dec; 17(8):687-93. PubMed ID: 11127401
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant status in beta thalassemia major: a single-center study.
Waseem F; Khemomal KA; Sajid R
Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in patients with beta-thalassemia major.
Pavlova LE; Savov VM; Petkov HG; Charova IP
Prilozi; 2007 Jul; 28(1):145-54. PubMed ID: 17921925
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of serum ferritin and iron burden by intake of antioxidants in beta thalassemia major.
Bhagat SS; Sarkar PD; Suryakar AN; Padalkar RK; Ghone RA; Patil SM; Hundekar PS
Indian J Physiol Pharmacol; 2013; 57(2):189-94. PubMed ID: 24617170
[TBL] [Abstract][Full Text] [Related]
7. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.
Livrea MA; Tesoriere L; Pintaudi AM; Calabrese A; Maggio A; Freisleben HJ; D'Arpa D; D'Anna R; Bongiorno A
Blood; 1996 Nov; 88(9):3608-14. PubMed ID: 8896430
[TBL] [Abstract][Full Text] [Related]
9. Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.
De Luca C; Filosa A; Grandinetti M; Maggio F; Lamba M; Passi S
Free Radic Res; 1999 Jun; 30(6):453-62. PubMed ID: 10400457
[TBL] [Abstract][Full Text] [Related]
10. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.
Kalpravidh RW; Siritanaratkul N; Insain P; Charoensakdi R; Panichkul N; Hatairaktham S; Srichairatanakool S; Phisalaphong C; Rachmilewitz E; Fucharoen S
Clin Biochem; 2010 Mar; 43(4-5):424-9. PubMed ID: 19900435
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy.
Llurba E; Gratacós E; Martín-Gallán P; Cabero L; Dominguez C
Free Radic Biol Med; 2004 Aug; 37(4):557-70. PubMed ID: 15256227
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status and plasma lipid profile in β-thalassemia patients.
Boudrahem-Addour N; Izem-Meziane M; Bouguerra K; Nadjem N; Zidani N; Belhani M; Djerdjouri B
Hemoglobin; 2015; 39(1):36-41. PubMed ID: 25395219
[TBL] [Abstract][Full Text] [Related]
14. The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial.
Darvishi-Khezri H; Salehifar E; Kosaryan M; Karami H; Alipour A; Shaki F; Aliasgharian A
Complement Ther Med; 2017 Dec; 35():25-32. PubMed ID: 29154063
[TBL] [Abstract][Full Text] [Related]
15. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress.
Dissayabutra T; Tosukhowong P; Seksan P
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S317-21. PubMed ID: 16623048
[TBL] [Abstract][Full Text] [Related]
16. Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
Yanpanitch OU; Hatairaktham S; Charoensakdi R; Panichkul N; Fucharoen S; Srichairatanakool S; Siritanaratkul N; Kalpravidh RW
Oxid Med Cell Longev; 2015; 2015():537954. PubMed ID: 26078808
[TBL] [Abstract][Full Text] [Related]
17. IMPAIRED ENDOTHELIAL FUNCTION IN PEDIATRIC HEMOGLOBIN E/β-THALASSEMIA PATIENTS WITH IRON OVERLOAD.
Aphinives C; Kukongviriyapan U; Jetsrisuparb A; Kukongviriyapan V; Somparn N
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1454-63. PubMed ID: 26466432
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 Levels in Beta Thalassemia Major and Minor Patients and Its Relationship With Antioxidant Capacity and Total Oxidant Stress.
Isık Balcı Y; Nuray E; Polat A; Enlı Y; Ozgurler F; Akın M
J Pediatr Hematol Oncol; 2016 Jan; 38(1):12-6. PubMed ID: 26599985
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress.
Ozturk Z; Genc GE; Kupesiz A; Kurtoglu E; Gumuslu S
Free Radic Res; 2015 Mar; 49(3):309-16. PubMed ID: 25564095
[TBL] [Abstract][Full Text] [Related]
20. Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects.
Ferro E; Visalli G; Civa R; La Rosa MA; Randazzo Papa G; Baluce B; D'Ascola DG; Piraino B; Salpietro C; Di Pietro A
Free Radic Biol Med; 2012 Nov; 53(10):1829-37. PubMed ID: 22995637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
